Article Correctness Is Author's Responsibility: First Ever Clinical Trial Evaluating Keytruda in Combination with Focused Ultrasound for Metastatic ****** Cancer Begins at University of Virginia

For the first time, non-invasive focused ultrasound therapy is being used to ablate (or destroy) a portion of the primary tumor or metastatic tumors in conjunction with the cancer immunotherapy drug Keytruda.